New drug combo tested to control advanced lung cancer
Disease control
Completed
This study tested whether adding the drug bevacizumab to standard treatment (erlotinib) works better for controlling advanced lung cancer in Chinese patients with specific genetic mutations. The trial involved 311 adults with advanced non-small cell lung cancer who had not receiv…
Phase: PHASE3 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC